GSK PLC noted that Dr Hal Barron, a Non-Executive Director, was appointed an Independent Director and Chair of the Nominating and Corporate Governance Committee of Quantinuum Inc. on June 4, 2026.
Quantinuum Inc. Announces Board and Committee Changes
Published on 06/09/2026 at 12:51 pm EDT
S&P Capital IQ
© S&P Capital IQ -
Regulatory News Service -
2026

















